| Sign In to gain access to subscriptions and/or personal tools. |
Monoclonal Gammopathy in Systemic Lupus ErythematosusDepartment of Internal Medicine, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Paseo Vall d'Hebron s/n 08035, Barcelona, Spain
Department of Internal Medicine, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Paseo Vall d'Hebron s/n 08035, Barcelona, Spain
Department of Internal Medicine, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Paseo Vall d'Hebron s/n 08035, Barcelona, Spain
Department of Internal Medicine, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Paseo Vall d'Hebron s/n 08035, Barcelona, Spain
Department of Internal Medicine, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Paseo Vall d'Hebron s/n 08035, Barcelona, Spain
Department of Internal Medicine, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Paseo Vall d'Hebron s/n 08035, Barcelona, Spain In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstrating a higher incidence of MG in SLE patients in comparison with the general population. Neither the clinical importance nor the pathogenetic significance of this association is known.
Key Words: Systemic lupus erythematosus Monoclonal gammopathy
Lupus, Vol. 1, No. 4,
263-264 (1992) This article has been cited by other articles:
|
|||||||||||||||
